A Clinical Trial Evaluating the Effects of Ultra-Violet C treatment (UVC) during Ex Vivo Lung Perfusion (EVLP) as a Method of Inactivating Hepatitis C Infection in Donor Lungs
In pre-clinical studies we have demonstrated the ability of light-based therapies - UVC and photodynamic therapy (PDT) during EVLP to inactivate HCV in donor lungs. In a step-wise application of this technology to clinical transplantation, we designed a clinical trial to evaluate to effects of UVC treatment using NAT+ HCV donor lungs followed by transplantation.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: M. Cypel, M. Galasso, R. Ribeiro, B. Wilson, V. Bagnato, C. Kurachi, M. Chen, D. Kumar, T.K. Waddell, L.G. Singer, S. Keshavjee, A. Humar, J. Feld Tags: 108 Source Type: research
More News: Cardiology | Clinical Trials | Heart | Heart Transplant | Hepatitis | Hepatitis C | Lung Transplant | Perfusion | Study | Transplant Surgery | Transplants